) (100) (50) - 50 100 Q 1 2 0 1 9 Q 1 2 0 1 8 Statements of Cash Flows Dividend payment The company had the dividend payment policy stipulated that dividends shall be paid at the rate of not less than 40
the increase in total production cost, the company and subsidiary still could generate the Cash Margin which indicate that the Company was well in operation management. Net gain on foreign exchange rate
Gross profit 47.04 31.23 34.05 2.82 9.03 -12.99 -27.62 Profit (Loss) from exchange rate -0.21 0.54 3.24 2.70 500.00 3.45 -1,614.02 Other Income 1.46 2.1 2.02 -0.08 -3.81 0.56 38.36 Gain from bargain
results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
International Hospital” to the Group. The finance costs decreased in the amount of Baht 5.9 million or 15.3% which in line with the management of interest rate of long-term debts. - Income tax for Q1/2018 in the
growth rate of 9.05%. Cost of hospital operations The cost of hospital operations amounted to Baht 134.79 million and Baht 146.47 million in the six-month period ended June 30, 2017 and the six-month
. Administrative expenses decreased by Baht 7 million due mainly to a decrease in loss on exchange rate and repair & maintenance expenses. Share of loss from investment in associates decreased by Baht 20 million
increased at a rate of 3.2% over same period of last year which, in accordance with the policy, demonstrated the efficiency of Company cost control management. - Nevertheless, Company had incurred somewhat
in Hotel Business. Other Business growth came from the gain from the sale of investments, the share of profit from investment in food business (as invested in 1Q18), and gain on foreign exchange rate
than THB 160 million. (no collateral) Interest Rate : 3.50% per annum. Maturity : Not more than 3 years starting from August 25th, 2018 until August 24th, 2021. Interest Payment : Monthly Nature of